Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor

Hippocampus

Volumn 17, Issue 4, 2007, Pages 271-280

  Ishida, Hisahito ^a   Shirayama, Yukihiko ^a,b   Iwata, Masaaki ^a   Katayama, Seiji ^a   Yamamoto, Ayaka ^a   Kawahara, Ryuzou ^a   Nakagome, Kazuyuki ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Behavior; Depression; Hippocampus; Learned helplessness (LH); Neuropeptide Y (NPY)

Indexed keywords

LEUCYLPROLYL PEPTIDE YY; N [2 [1,2 DIHYDRO 3,5(4H) DIOXO 1,2 DIPHENYL 1,2,4 TRIAZOL 4 YL]ETHYL] N2 [[1 [2 [4 [5,11 DIHYDRO 6(6H) OXODIBENZ[B,E]AZEPIN 11 YL] 1 PIPERAZINYL] 2 OXOETHYL]CYCLOPENTYL]ACETYL]ARGININAMIDE; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PEPTIDE YY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVERSION; DENTATE GYRUS; DEPRESSION; DRUG RECEPTOR BINDING; HIPPOCAMPUS; LEARNED HELPLESSNESS; LEARNING; LOCOMOTION; NONHUMAN; OPEN FIELD BEHAVIOR; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZAZEPINES; DEPRESSION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXPLORATORY BEHAVIOR; HELPLESSNESS, LEARNED; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROPEPTIDE Y; PEPTIDE YY; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 34247548709     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20264     Document Type: Article

References (74)

1. Alt A, Witkin JM, Bleakman D. 2005. AMPA receptor potentiators as novel antidepressants. Curr Pharm Des 11:1511-1527.
2. Anisman H, Suissa A, Sklar LS. 1980. Escape deficits induced by uncontrollable stress: Antagonism by dopamine and norepinephrine agonists. Behav Neural Biol 28:34-47.
3. Bellmann R, Sperk G. 1993. Effects of antidepressant treatment on levels of NPY or prepro-NPY- mRNA in the rat brain. Neurochem Int 22:183-187.
4. Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. Eur Neuropsychopharmacol 17:172-179.
5. Bowers G, Cullinan WE, Herman JP. 1998. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits. J Neurosci 18:5938-5947.
6. Caberlotto L, Fuxe K, Overstreet DH, Gerrard P, Hurd YL. 1998. Alterations in neuropeptide Y, Y1 receptor mRNA expression in brains from an animal model of depression: Region specific adaptation after fluoxetine treatment. Mol Brain Res 59:58-65.
7. Caberlotto L, Jimenez P, Overstreet DH, Hurd YL, Mathe AA, Fuxe K. 1999. Alterations in neuropeptide Y levels and Y1 binding sites in Flinders Sensitive rats, a genetic animal model of depression. Neurosci Lett 265:191-194.
8. Chen ACH, Shirayama Y, Shin KH, Neve RL, Duman RS. 2001. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry 49:753-762.
9. Conrad CD, McEwen BS. 2000. Acute stress increases neuropeptide Y mRNA within the arcuate nucleus and hilus of the dentate gyrus. Mol Brain Res 79:102-109.
10. Croll SD, Wiegand SJ, Anderson KD, Lindsay RM, Nawa H. 1994. Regulation of neuropeptides iri adult rat forebrain by the neurotrophins BDNF and NGF. Eur J Neurosci 6:1343-1353.
11. B receptors in anxiety and depression. Trends Pharmacol Sci 26:36-43.
12. Duman RS, Heninger GR, Nestler EJ. 1997. A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606.
13. Ehlers CL, Li TK, Lumeng L, Hwang BH, Some C, Jiménez PA, Marné AA. 1998. Neuropeptide Y levels in ethanol-naïve alcohol-preferring and nonpreferring rats and in Wistar rats after ethanol exposure. Alcohol Clin Exp Res 22:1778-1782.
14. Ferry B, Roozendaal B, McGaugh JL. 1999. Basolateral amygdala noradrenergic influences on memory storage are mediated by an interaction beta- and alpha1 adrenoreceptors. J Neurosci 19:5119-5123.
15. Gjerris A, Widerlov E, Werdelin L, Ekman R. 1992. Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls. J Psychiatry Neurosci 17:23-27.
16. Hashimoto H, Onishi H, Koide S, Kai T, Yamagami S. 1996. Plasma neuropeptide Y in patients with major depressive disorder. Neurosci Lett 216:57-60.
17. Heilig M, Ekman R. 1995. Chronic parenteral antidepressant treatment in rats: Unaltered levels and processing of neuropeptide Y (NPY) and corticotropin-releasing hormone (CRH). Neurochem Int 26:351-255.
18. Heilig M, Zachrisson O, Thorsell A, Ehnvall A, Mottagui-Tabar S. Sjögren M, Åsberg M, Ekman R, Wahlestedt C, Ågren H. 2004. Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: Preliminary evidence for association with preproNPY gene polymorphism. J Psychiat Res 38:113-121.
19. Holmes A, Heilig M, Rupniak NMJ, Steckler T, Griebel G. 2003. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24:580-588.
20. Howell OW, Scharfman HE, Herzog H, Sundstorm LE, Beck-Sickinger A, Gray WP. 2003. Neuropeptide-Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem 86:646-659.
21. Husum H, Mathé AA. 2002. Early life stress changes concentrations of neuropeptide Y, corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology 27:756-764.
22. Husum H, Mikkelsen JD, Hogg S, Mathé AA, Mørk A. 2000. Involvement of hippocampal neuropeptie Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram. Neuropharmacology 39:1463-1473.
23. Husum H, Jimenez-Vasquez PA, Mathé AA. 2001. Changed concentrations of tachykinins and neuropeptide Y in brain of a rat model of depression: Lithium treatment normalizes tachykinins. Neuropsychopharmacology 24:183-191.
24. Husum H, van Kammen D, Termeer E, Bolwig TG, Mathé AA 2003. Topiramate normalizes hippocampal NPY-LI in Flinders Sensitive Line 'Depressed' rats and upregulates NPY, galanin, and CRH-LI in the hypothalamus: Implications for mood-s tabilizing and weight loss-inducing effects. Neuropsychopharmacology 28:1292-1299.
25. Ishida H, Shirayama Y, Iwata M, Kawahara R. 2005. Subchronic treatment with imipramine ameliorates the decreased number in neuropeptide Y-positive cells in the hippocampus of learned helplessness rats. Brain Res 1046:239-243.
26. Iwata M, Shirayama Y, Ishida H, Kawahara R. 2006. Hippocampal synapsin I, growth-associated protein-43, and microtuble-associated protein-2 immunoreactivity in learned helplessness rats and antidepressant-treated rats. Neuroscience 141:1301-1313.
27. Jiménez-Vasquez P, Salmi P, Ahlenius S, Mathé AA. 2000. Neuropeptide Y in brain of the Flinders sensitive line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptide concentrations and locomotion. Behav Brain Res 111:115-123.
28. Jiménez-Vasquez P, Mathé AA, Thomas JD, Riley EP, Ehlers CL. 2001. Early maternal separation alters neuropeptide Y concentrations in selected brain regions in adult rats. Brain Res Dev Brain Res 131:149-152.
29. Kametani H, Nomura S, Shimizu J. 1983. The reversal effect of antidepressants on the escape deficit induced by inescapable shock in rats. Psycopharmacology 80:206-208.
30. Karasawa J, Shimazaki T, Kawashima N, Chaki S. 2005. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist. Brain Res 1042:92-98.
31. Kempermann G, Kronenberg G. 2003. Depressed new neurons - Adult hippocampal neurogenesis and a cellular plasticity hypothesis of major depression. Biol Psychiatry 54:499-503.
32. Kofler N, Kirchmair E, Schwarzer C, Sperk G. 1997. Altered expression of NPY-Y1 receptors in kainic acid-induced epilepsy in rats. Neurosci Lett 230:129-132.
33. Kohler C, Eriksson L, Davies S, Chan-Palay V. 1986. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol 244:384-400.
34. Kragh J, Tender N, Finsen BR, Zimmer J, Bolwig TG. 1994. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp Brain Res 98:305-313.
35. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7:S71-S80.
36. Lacroix L, Broersen LM, Weiner I, Feldon J. 1998. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 84:431-442.
37. Lim S, Ryu YH, Kim ST, Hong MS, Park HJ. 2003. Acupuncture increases neuropeptide Y expression in hippocampus of maternally-separated rats. Neurosci Lett 343:49-52.
38. Ma XM, Mains RE, Eipper BA. 2002. Plasticity in hippocampal peptidergic systems induced by repeated electroconvulsive shock. Neuropsychopharmacology 27:55-71.
39. Mathé AA, Rudorfer MV, Stenfors C, Manji HK, Potter WC, Theodorsson E. 1996. Effects of electroconvulsive treatment on somatostain, neuropeptide Y, endothelin and neurokinin A concentrations in cerebrospinal fluid of depressive patients. Depression 3:250-256.
40. Mathé AA, Gruber S, Jiménesz PA, Theodorsson E, Stenfors C. 1997. Effect of electroconvulsive stimuli and MK-801 on neuropeptide Y, neurokinin A, calcitonin gene-related peptide in rat brain. Neurochem Res 22:629-636.
41. Mathé AA, Jiménesz PA, Theodorsson E, Stenfors C. 1998. Neuropeptide Y, neurokinin A, neurotensin in brain regions of Fawn Hooded "depressed", Wistar and Sprague-Dawley rats. Effects of electroconvulsive stimuli. Prog Neuropsychopharmacol Biol Psychiatry 22:529546
42. 5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA 96:13518-13523.
43. Marty S, Onteniente B. 1999. BDNF and NT-4 differentiate two pathways in the modulation of neuropeptide protein levels in post-natal hippocampal interneurons. Eur J Neurosci 11:1647-1656.
44. McCarthy JB, Walker M, Pierce J, Camp P, White JD. 1998. Biosynthesis and Metabolism of native and oxidized neuropeptide-Y in the hippocampal mossy fiber system. J Neurochem 70:1950-1963.
45. Mikkelsen JD, Woldbye DPD, Kragh J, Larsen PJ, Bolwig TG. 1994. Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Mol Brain Res 23:317-322.
46. Morgan CA III, Rasmusson AM, Wang S, Hoyt G, Hauger RL, Hazlett G. 2002. Neuropeptide-Y, Cortisol, and subjective distress: Replication and extension of previous report. Biol Psychiatry 52:136-142.
47. Nilsson C, Karlsson G, Blennow K, Heilig M, Ekman R. 1995. Differences in the neuropeptide Y-like immunoreactivity of the plasma and platelets of human volunteers and depressed patients. Peptides 17:359-362.
48. Obuchowicz E, Krysiak R, Herman ZS. 2004. Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs? Neurosci Biobehav Rev 28:595-610.
49. A receptor subunit mRNA levels in rat hippocampus. Mol Brain Res 34:29-37.
50. Overmier JO, Seligman ME. 1967. Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol 63:28-33.
51. Parker MS, Sah R, Balasubramaniam A, Parker SL. 2005. Lithium inhibits internalization and endosomal processing of both neuropeptide Y (NPY) Y1 and transferring receptors. Neurosci Lett 374:43-46.
52. Pascual M, Acsady L, Rocamora N, Freund T, Soriano E. 1999. Expression of neurotrophins in hippocampal intemeurons immunoreactive for the neuropeptides somatostatin, neuropeptide-Y, vasoactive intestinal polypeptide and cholecystokinin. Neuroscience 89:1089-1101.
53. Paxinos G, Watson C. 1997. The Rat Brain in Stereotaxic Co-ordinates. New York: Academic Press.
54. Primeaux SD, Wilson SP, Cusick MC, York DA, Wilson MA. 2005. Effects of altered amygdalar neuropeptide Y expression on anxiety-related behaviors. Neuropsychopharmacology 30:1589-1597.
55. Redrobe JP, Dumont Y, Fournier A, Quirion R. 2002a. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 26:615-624.
56. Redrobe JP, Dumont Y, Quirion R. 2002b. Neuropeptide Y (NPY) and depression: From animal studies to the human condition. Life Sci 71:2921-2937.
57. Redrobe JP, Dumont Y, Fournier A, Baker GB, Quirion R. 2005. Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides 26:1394-1400.
58. Reibel S, Vivien-Roels B, Le B-T, Larmet Y, Camahan J, Marescaux C, Depaulis A. 2000. Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting. Eur J Neurosci 12:595-605.
59. Shirayama Y, Chen ACH, Nakagawa S, Russell DS, Duman RS. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261.
60. Shirayama Y, Ishida H, Iwata M, Hazama G, Kawahara R, Duman RS. 2004. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268.
61. Stenfors C, Srinivasan GR, Theodorsson E, Mathé AA. 1992. Electroconvulsive stimuli and brain peptides: Effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P, neurotensin. Brain Res 596:251-258.
62. Stogner KA, Holmes PV. 2000. Neuropeptide Y exerts antidepressant-like effects in the forced swim test in rats. Eur J Pharmacology 387:9-10.
63. Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. 1998. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396:366-369.
64. Thiele TE, Koh MT, Pedrazzini T. 2002. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J Neurosci 22:RC208.
65. Thiriet N, Deng X, Solinas M, Ladenheim B, Curtis W, Goldberg SR, Palmiter RD, Cadet JL. 2005. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J Neurosci 25:5273-5279.
66. Thorsell A, Michalkiewicz M, Dumont Y, Quirion R, Caberlotto L, Rimondini R, Mathé AA, Heilig M. 2000. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 97:12852-12857.
67. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, Herzog H, Sperk G. 2003. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148.
68. Vezzani A, Sperk G, Colmers WF. 1999. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation. Trends Neurosci 22:25-30.
69. Wahlestedt C, Blendy JA, Keller KJ, Heilig M, Widerlöv E, Ekman R. 1990. Electroconvulsive shock increases the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res 507:65-68.
70. Wahlestedt C, Pich EM, Koob GF, Yee F, Heilig M. 1993. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 259:528-531.
71. 2-type receptors in rat bran. Brain Res 539:196-202.
72. 5-like receptors. Nat Med 3:761-764.
73. Zachrisson O, Mathé AA, Stenfors C, Lindefors N. 1995a. Limbic effects of repeated electroconvulsive stimulation on neuropeptideY and somatostatin mRNA expression in the rat brain. Mol Brain Res 31:71-85.
74. Zachrisson O, Mathé AA, Stenfors C, Lindefors N. 1995b. Region-specific effects of chronic lithium administration on neuropeptide Y, somatostatin mRNA expression in the rat brain. Neurosci Lett 194:89-92.